Livin/BIRC7 expression as malignancy marker in adrenocortical tumors. - Wikidata - awgldk - TriplyDB

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

http://www.wikidata.org/entity/Q37705961

about

LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein.

P2860

Q50674825-D381ED69-6447-4D4A-8626-BBA7896B5CC1

P2860

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

http://www.wikidata.org/entity/Q37705961

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

@en

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

@nl

type

label

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

@en

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

@nl

prefLabel

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

@en

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.

@nl

P1433

Q37705961-439C3A1C-5570-44F7-AB3E-C13D2863B63B

P1476

Q37705961-21441CA8-96FE-4E7C-9260-0B605E9E7192

P2093

Q37705961-6B647CF5-6AC0-4233-BCBC-3BB09B2E62BB

Q37705961-82C4CDD4-5A84-4B7E-8BE2-EE99568E7B37

Q37705961-8DB65D98-28BA-4BED-BA27-CBBC9359E1CD

Q37705961-950DD0C4-CDEB-4213-8DC2-D8CF36E7E5A2

Q37705961-9CCA2677-C7C9-4337-BE16-585EE7F257A2

Q37705961-AFB72D1E-0150-47D9-9F64-A932F7CEFAD0

Q37705961-B97ACBEC-4016-410C-A48C-42B169360891

Q37705961-CEDF1FC6-C110-4BC5-A9DF-A6967CEA20A3

Q37705961-DE6CA52B-122F-475B-B49B-DB728CC6383A

Q37705961-DF1DB76F-B8ED-4DC4-AF45-F0C0EC9500CA

P2860

Q37705961-047F1BC6-47D9-4EFD-8BBD-9D1DD106450D

Q37705961-06B117FD-0296-4D50-87FB-C243290C1850

Q37705961-0E9C3098-2528-4D7C-B746-E047970F1F32

Q37705961-240D6C81-69A5-4E28-87C8-980DAFBE6AAB

Q37705961-2788F6E5-17E2-4D4A-B9DE-FB9940C1D0F5

Q37705961-2827FB50-5B73-4F71-99C9-FD6AFC3409FB

Q37705961-2E9D8D2B-D14C-49BF-921A-F47704D818D0

Q37705961-33552CD5-4EDA-45D2-9B7E-0A74CD1D0F22

Q37705961-3BF25F1A-6809-4AF6-A545-CEE5184BE8FD

Q37705961-3FECF018-8665-40EA-841A-31BCDC02329F

P304

Q37705961-5DBF9B59-41CE-46CF-A6CD-7D9A2A69909B

P31

Q37705961-3055029A-CEE8-4904-9D1A-FECC9EFD276A

P356

Q37705961-F3A8391A-8618-499B-A734-99429B15537E

P407

Q37705961-035D81E0-EB43-49F3-AD75-6BF5931957E2

P433

Q37705961-9EDB220E-A9E6-422F-90D5-42A0CB2883FD

P478

Q37705961-2A2F2658-EA99-4F5A-A17D-823AF673A290

P50

Q37705961-76424916-9C79-493D-A9FB-5E9B3E40F955

Q37705961-86240068-F050-4DCF-95DD-C455C8AC50B9

Q37705961-B53BED6C-634F-439C-85AB-FA906E489E1B

Q37705961-FC882A97-4676-4F0A-9F62-0AAC247DF21B

P577

Q37705961-8AD88A80-544A-4347-9BCF-E5E5D5E6D2B1

P698

Q37705961-6595992A-B95A-46A5-B160-7E8503DEFD51

P932

Q37705961-0816E8DD-BD90-4BD6-8229-FA40778AF5E9

P356

ONCOTARGET.14067

P1433

P1476

Livin/BIRC7 expression as malignancy marker in adrenocortical tumors

@en

P2093

Alfredo Pontecorvi

http://www.w3.org/2001/XMLSchema#string

Andreas Rosenwald

http://www.w3.org/2001/XMLSchema#string

Arkadius Kocot

http://www.w3.org/2001/XMLSchema#string

Egle M Mambretti

http://www.w3.org/2001/XMLSchema#string

Guido Fadda

http://www.w3.org/2001/XMLSchema#string

Isabel Weigand

http://www.w3.org/2001/XMLSchema#string

Michaela Bekteshi

http://www.w3.org/2001/XMLSchema#string

Silvia Della Casa

http://www.w3.org/2001/XMLSchema#string

Sonja Steinhauer

http://www.w3.org/2001/XMLSchema#string

Vanessa Wild

http://www.w3.org/2001/XMLSchema#string

P2860

Livin, a novel inhibitor of apoptosis protein family member

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin

Future directions in the diagnosis and medical treatment of adrenocortical carcinoma

Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)

Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs

The challenge of developmental therapeutics for adrenocortical carcinoma

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells

P304

9323-9338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.14067

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Cristina L Ronchi

Barbara Altieri

Martin Fassnacht

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28030838

http://www.w3.org/2001/XMLSchema#string

P932

5354734

http://www.w3.org/2001/XMLSchema#string